Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings
What will members gain?

Download Now: New Slide Deck Programme

Slide decks focusing on key results and expert analysis from FOURIER, ODYSSEY OUTCOMES and ODYSSEY trials – all landmark trials in PCSK9 inhibition.

Find out more »

Hot Topics

Targeting the right patients for PCSK9 inhibition – ODYSSEY OUTCOMES offers new insights

How do clinicians ensure they gain the best value from PCSK9 inhibition in their very high-risk patients? New subgroup analyses from ODYSSEY OUTCOMES provide important insights.

Read the Report

Professor Gregory Schwartz (University of Colorado School of Medicine, Aurora, USA) discusses
Watch the Video
Professor Philippe Gabriel Steg (Assistance Publique-Hôpitaux de Paris, Paris, France) gives his view
Watch the Video

From the Editors

Are we doing any better with familial hypercholesterolaemia care?

Professor Eric Bruckert, Pitié-Salpêtrière Hospital, Paris, France
Has the care of this common inherited disorder, characterised by high cholesterol levels from birth, improved in the last 5 years? What can we learn from the only global registry?

Read the report
Insights from the EAS FHSC Registry, Prof. Eric Bruckert
Watch the video
Too little, too late: Prof. Raul Santos discusses the EAS FHSC Registry data
Watch the video
2019 ESC/EAS Dyslipidaemia Guidelines and FH, Prof. Eric Bruckert
Watch the video

ACC 2017

Meet our Editorial Board

View all our Editorial Board Prof John ChapmanResearch Professor at the University of Pierre and Marie Curie Prof Henry GinsbergDirector, Irving Institute for Clinical and Translational Research Dr Michel FarnierClinician based at Point Medical, Dijon, France Prof Frederick RaalDirector, Carbohydrate & Lipid Metabolism Research Unit Prof Anthony WierzbickiConsultant in Metabolic Medicine/Chemical Pathology